Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether his Department has had discussions with NICE on the Afinitor form of everolimus.

Departmental officials are in regular contact with their counterparts at the National Institute for Health and Care Excellence (NICE) about a range of issues, including individual medicines. This includes discussions on everolimus through the established topic selection processes for NICE’s technology appraisal programme and in relation to potential patient access schemes proposed by the manufacturer.

NICE has appraised everolimus for a number of indications and is currently appraising it for others.